Target intelligence / Profile preview

EF-hand calcium-binding domain-containing protein 1 (CLXN)

Target
CLXN
Molecular classification
EF-hand calcium-binding protein, not a receptor, enzyme, transporter, or canonical drug target
01

Overview

EF-hand calcium-binding domain-containing protein 1 (CLXN, also known as Calaxin) is a calcium-binding protein that is a component of the outer dynein arm-docking complex (ODA-DC)[3][7][5]. It mediates the attachment of the outer dynein arms to doublet microtubules in motile cilia and flagella, which is essential for their movement[3][11][7][5]. The protein plays a key role in cilium motility, regulation of sperm flagellar motility, and is required for proper assembly of the outer dynein arms onto ciliary microtubules[3][7][5]. Calaxin contains EF-hand domains, which are structural motifs involved in calcium ion binding[1][6][10]. Pathogenic variants are associated with primary ciliary dyskinesia, Kartagener syndrome, and related disorders affecting motile cilia and sperm function[3][11]. There is no evidence currently that this protein serves as a therapeutic target for drugs, nor are there established interacting drugs, known mechanisms of drug action, or clinical biomarkers for CLXN[3].

Other names
CalaxinCLXNEFCAB1ODAD5FLJ11767CILD53EF-hand calcium-binding domain-containing protein 1outer dynein arm docking complex subunit 5
02

Biological functions

Calcium ion bindingCilium movementRegulation of flagellated sperm motilityOuter dynein arm assembly
03

Disease associations

Ciliary dyskinesia (including primary ciliary dyskinesia type 53)Kartagener syndromedefects in sperm motility

Beyond the preview

Go deeper on EF-hand calcium-binding domain-containing protein 1 (CLXN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EF-hand calcium-binding domain-containing protein 1 (CLXN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call